{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:52:00Z","timestamp":1793710320455,"version":"4.6.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulmonary fibrosis is a chronic progressive lung disease with few treatments. Human mesenchymal stem cells (MSCs) have been shown to be beneficial in pulmonary fibrosis because they have immunomodulatory capacity. However, there is no reliable model to test the therapeutic effect of human MSCs in vivo. To mimic pulmonary fibrosis in humans, we established a novel bleomycin-induced pulmonary fibrosis model in humanized mice. With this model, the benefit of human MSCs in pulmonary fibrosis and the underlying mechanisms were investigated. In addition, the relevant parameters in patients with pulmonary fibrosis were examined. We demonstrate that human CD8+ T cells were critical for the induction of pulmonary fibrosis in humanized mice. Human MSCs could alleviate pulmonary fibrosis and improve lung function by suppressing bleomycin-induced human T-cell infiltration and proinflammatory cytokine production in the lungs of humanized mice. Importantly, alleviation of pulmonary fibrosis by human MSCs was mediated by the PD-1\/programmed death-ligand 1 pathway. Moreover, abnormal PD-1 expression was found in circulating T cells and lung tissues of patients with pulmonary fibrosis. Our study supports the potential benefit of targeting the PD-1\/programmed death-ligand 1 pathway in the treatment of pulmonary fibrosis.<\/jats:p>","DOI":"10.1165\/rcmb.2017-0326oc","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T17:20:12Z","timestamp":1512753612000},"page":"684-695","source":"Crossref","is-referenced-by-count":92,"title":["PD-1\/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice"],"prefix":"10.1093","volume":"58","author":[{"given":"Ke","family":"Ni","sequence":"first","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kowk-Tai","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey Chi-Fung","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lung","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-8798","authenticated-orcid":false,"given":"Wenwei","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"2026012222030121300_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol"},{"key":"2026012222030121300_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"2026012222030121300_bib3","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(11)60546-1","article-title":"Pirfenidone for idiopathic pulmonary fibrosis","volume":"377","author":"Bouros","year":"2011","journal-title":"Lancet"},{"key":"2026012222030121300_bib4","first-page":"359","article-title":"Update on therapeutic management of idiopathic pulmonary fibrosis","volume":"11","author":"Tzouvelekis","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"2026012222030121300_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2466-14-139","article-title":"Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature","volume":"14","author":"Kistler","year":"2014","journal-title":"BMC Pulm Med"},{"key":"2026012222030121300_bib6","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012222030121300_bib7","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012222030121300_bib8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"2026012222030121300_bib9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J Exp Med"},{"key":"2026012222030121300_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/1574888X10666150519092639","article-title":"Stem cell and idiopathic pulmonary fibrosis: mechanisms and treatment","volume":"10","author":"Liu","year":"2015","journal-title":"Curr Stem Cell Res Ther"},{"key":"2026012222030121300_bib11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/thx.51.10.1036","article-title":"T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice","volume":"51","author":"Suzuki","year":"1996","journal-title":"Thorax"},{"key":"2026012222030121300_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1\u03b2-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J Exp Med"},{"key":"2026012222030121300_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1165\/ajrcmb.24.5.4064","article-title":"Attenuation of lung inflammation and fibrosis in interferon-\u03b3-deficient mice after intratracheal bleomycin","volume":"24","author":"Chen","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222030121300_bib14","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.4049\/jimmunol.173.5.3425","article-title":"Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4\/IL-13 and mediation via STAT-6","volume":"173","author":"Liu","year":"2004","journal-title":"J Immunol"},{"key":"2026012222030121300_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1164\/rccm.201306-1141WS","article-title":"Future directions in idiopathic pulmonary fibrosis research: an NHLBI workshop report","volume":"189","author":"Blackwell","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030121300_bib16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1164\/rccm.200609-1347OC","article-title":"Dendritic cells accumulate in human fibrotic interstitial lung disease","volume":"176","author":"Marchal-Somm\u00e9","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030121300_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-9255-4-14","article-title":"CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis","volume":"4","author":"Papiris","year":"2007","journal-title":"J Inflamm (Lond)"},{"key":"2026012222030121300_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12015-011-9312-0","article-title":"Immunosuppressive properties of mesenchymal stem cells","volume":"8","author":"Abumaree","year":"2012","journal-title":"Stem Cell Rev"},{"key":"2026012222030121300_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-5-19","article-title":"Clinical applications of mesenchymal stem cells","volume":"5","author":"Wang","year":"2012","journal-title":"J Hematol Oncol"},{"key":"2026012222030121300_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/cmi.2010.57","article-title":"Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases","volume":"8","author":"Lin","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"2026012222030121300_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1378\/chest.10-0518","article-title":"Therapeutic potential of mesenchymal stem cells for severe acute lung injury","volume":"138","author":"Matthay","year":"2010","journal-title":"Chest"},{"key":"2026012222030121300_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1479-5876-11-171","article-title":"A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis","volume":"11","author":"Tzouvelekis","year":"2013","journal-title":"J Transl Med"},{"key":"2026012222030121300_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/resp.12343","article-title":"A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Chambers","year":"2014","journal-title":"Respirology"},{"key":"2026012222030121300_bib24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.chest.2016.10.061","article-title":"Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): a phase I safety clinical trial","volume":"151","author":"Glassberg","year":"2017","journal-title":"Chest"},{"key":"2026012222030121300_bib25","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.5966\/sctm.2015-0121","article-title":"Mesenchymal stromal cells in animal bleomycin pulmonary fibrosis models: a systematic review","volume":"4","author":"Srour","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"2026012222030121300_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/cdd.2013.149","article-title":"Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species","volume":"21","author":"Su","year":"2014","journal-title":"Cell Death Differ"},{"key":"2026012222030121300_bib27","doi-asserted-by":"crossref","first-page":"11771","DOI":"10.1074\/jbc.M112.448126","article-title":"Structure and interactions of the human programmed cell death 1 receptor","volume":"288","author":"Cheng","year":"2013","journal-title":"J Biol Chem"},{"key":"2026012222030121300_bib28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2026012222030121300_bib29","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20110226","article-title":"The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a \u03b3\u03b4 T cell population in humanized mice","volume":"208","author":"Tu","year":"2011","journal-title":"J Exp Med"},{"key":"2026012222030121300_bib30","doi-asserted-by":"crossref","first-page":"168ra9","DOI":"10.1126\/scitranslmed.3004943","article-title":"Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice","volume":"5","author":"Zheng","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026012222030121300_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccr.2014.07.026","article-title":"Targeted activation of human V\u03b39V\u03b42-T cells controls Epstein-Barr virus-induced B cell lymphoproliferative disease","volume":"26","author":"Xiang","year":"2014","journal-title":"Cancer Cell"},{"key":"2026012222030121300_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-015-0007-0","article-title":"Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB\/c host graft versus host disease murine models","volume":"4","author":"Robles","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"2026012222030121300_bib33","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.1301828","article-title":"IDO-independent suppression of T cell effector function by IFN-\u03b3-licensed human mesenchymal stromal cells","volume":"192","author":"Chinnadurai","year":"2014","journal-title":"J Immunol"},{"key":"2026012222030121300_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JIR.S40673","article-title":"Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis","volume":"6","author":"Todd","year":"2013","journal-title":"J Inflamm Res"},{"key":"2026012222030121300_bib35","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.176.10.5735","article-title":"Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis","volume":"176","author":"Marchal-Somm\u00e9","year":"2006","journal-title":"J Immunol"},{"key":"2026012222030121300_bib36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fimmu.2016.00516","article-title":"Skewed lung CCR4 to CCR6 CD4+ T cell ratio in idiopathic pulmonary fibrosis is associated with pulmonary function","volume":"7","author":"Adegunsoye","year":"2016","journal-title":"Front Immunol"},{"key":"2026012222030121300_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1465-9921-6-81","article-title":"CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis","volume":"6","author":"Daniil","year":"2005","journal-title":"Respir Res"},{"key":"2026012222030121300_bib38","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.4049\/jimmunol.1500777","article-title":"IL-21 promotes pulmonary fibrosis through the induction of profibrotic CD8+ T cells","volume":"195","author":"Brodeur","year":"2015","journal-title":"J Immunol"},{"key":"2026012222030121300_bib39","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/leu.2011.108","article-title":"Mesenchymal stromal cell \u2018licensing\u2019: a multistep process","volume":"25","author":"Krampera","year":"2011","journal-title":"Leukemia"},{"key":"2026012222030121300_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","article-title":"How mesenchymal stem cells interact with tissue immune responses","volume":"33","author":"Shi","year":"2012","journal-title":"Trends Immunol"},{"key":"2026012222030121300_bib41","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2026012222030121300_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.febslet.2004.07.083","article-title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70\/CD3\u03b6 signalosome and downstream signaling to PKC\u03b8","volume":"574","author":"Sheppard","year":"2004","journal-title":"FEBS Lett"},{"key":"2026012222030121300_bib43","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","article-title":"Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects","volume":"100","author":"Ortiz","year":"2003","journal-title":"Proc Natl Acad Sci USA"}],"updated-by":[{"DOI":"10.1165\/rcmb.v64erratum3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/58\/6\/684\/66467388\/ajrcmb_58_6_684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/58\/6\/684\/66467388\/ajrcmb_58_6_684.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:03:40Z","timestamp":1769137420000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/58\/6\/684\/8430639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2017-0326oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,6,1]]}}}